Using imaging to predict weight loss success after bariatric surgery
Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)
This study is testing if looking at CT scans of belly fat can help predict how much weight people will lose and if their type 2 diabetes will improve after bariatric surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 800 (estimated) |
| Ages | 16 Years to 70 Years |
| Sex | All |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06169033 on ClinicalTrials.gov |
What this trial studies
This study aims to analyze abdominal CT scans of patients scheduled for bariatric surgery to extract radiomic features from intra-abdominal and subcutaneous fat. By combining these imaging data with clinical characteristics, the researchers will develop a predictive model to assess the potential weight loss and remission of type 2 diabetes mellitus at 1, 3, and 5 years post-surgery. The observational nature of the study allows for a comprehensive understanding of how these factors correlate with surgical outcomes.
Who should consider this trial
Good fit: Ideal candidates include individuals with a BMI greater than 27.5 kg/m2 who have type 2 diabetes and are planning to undergo bariatric surgery.
Not a fit: Patients who do not have an abdominal CT scan or who are not undergoing sleeve gastrectomy or Roux-en-Y gastric bypass may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify patients who are more likely to benefit from bariatric surgery, leading to improved treatment outcomes.
How similar studies have performed: While the use of radiomics in predicting surgical outcomes is an emerging field, similar studies have shown promise in other areas of medicine, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI\>27.5kg/m2; Type 2 diabetes mellitus; Patients who will undergo bariatric surgery Exclusion Criteria: * Patients without abdominal CT scan; Patients did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass.
Where this trial is running
Beijing
- Yuntao Nie — Beijing, China (Recruiting)
Study contacts
- Principal investigator: Yuntao Nie, M.D. — China-Japan Friendship Hospital
- Study coordinator: Yuntao Nie, M.D.
- Email: nytnyt1231@163.com
- Phone: +8618611835860
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.